EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access

Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged

Gerald S Werner, David Hildick-Smith, For The EuroCTO Trial Investigators

EuroIntervention · 2024

DOI: 10.4244/eij-d-23-00857 ↗

Kurz gefasst

Leserbrief in der Zeitschrift EuroIntervention, 2024. Verfasst von Gerald S Werner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Klinikum Darmstadt GmbH, Darmstadt, Germany. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Vascular Diseases, Coronary Occlusion. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Percutaneous Coronary InterventionVascular DiseasesCoronary OcclusionHumansTreatment OutcomeChronic DiseaseCoronary AngiographyRisk Factors

Autor:innen und Institutionen

  • Klinikum Darmstadt GmbH, Darmstadt, Germany.
  • Sussex Cardiac Centre, University Hospitals Sussex NHS Foundation Trust, Brighton, United Kingdom.

Zitieren

APA

Werner, G. S., Hildick-Smith, D., & Trial Investigators, F. T. E. (2024). Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged. EuroIntervention. https://doi.org/10.4244/eij-d-23-00857

Vancouver

Werner GS, Hildick-Smith D, Trial Investigators FTE. Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged. EuroIntervention. 2024. doi:10.4244/eij-d-23-00857

BibTeX
@article{Werner2024,
  author = {Werner, Gerald S and Hildick-Smith, David and Trial Investigators, For The EuroCTO},
  title = {Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged},
  journal = {EuroIntervention},
  year = {2024},
  doi = {10.4244/eij-d-23-00857}
}
Kostenlos starten →